level with the hyoid bone, and are closely related to the carotid artery pulsation. A single lump just in front ofthe anterior edge of the upper third of the sternomastoid muscle, closely related to an arterial pulse, must always be regarded with suspicion and investigated by Doppler or conventional arteriography. The arteriographic features-a vascular tumour between a widened carotic bifurcation-are diagnostic. Both sides of the neck should be investigated as carotid body tumours may be bilateral.1-3 They may also be familial.1"
The second and third problems are inseparable: the pathological nature ofthe tumour and its treatment. Macroscopically these tumours have been divided into three varieties-those loosely attached to the vessels, those adherent to the adventitia of the carotid artery but dissectable from it, and those so intimately adherent that they are difficult to remove without making a hole in the adjacent arteries.4 In my experience these are technical subdivisions related more to the size of the tumour, the degree to which it surrounds the main arteries, and the difficulty of the operation than to real pathological variations. Local invasion does occur in a few cases (5%) and must be accepted as true local malignancy, but even in these cases the histological confirmation of malignant change can be difficult.5 6 Fewer than 5% of all tumours are eventually associated with distant metastases.3 These are only estimates of the incidence of malignant change because all the published series are small.
If left untreated carotid body tumours slowly but inexorably get larger. Eventually they will obstruct the adjacent internal carotid artery and possibly cause a stroke, but the precise chances of this catastrophe occurring have not been documented.
No surgeon should attempt to remove a carotid body tumour unless he is experienced in the surgical techniques used for carotid artery surgery for atheromatous disease. This means that any surgeon who finds such a tumour unexpectedly should stop the operation, without a biopsy, and arrange for the patient to have further investigations and re-exploration by an experienced vascular surgeon. To proceed unprepared with excision without the correct vascular instruments and surgical skill is hazardous and might cause a stroke-an unacceptable complication of what the patient had probably been told was to be a simple biopsy of a node.
In most cases the tumour can be removed without damaging the carotid artery by dissecting within or just deep to the adventitia.7 This dissection is always bloody but the oozing stops as soon as the tumour is free. An essential preliminary is the isolation of the vessels above and below the tumour so that they can be controlled in the event of sudden bleeding. Large tumours which completely surround the common or internal carotid artery and tumours which seem to be infiltrating the artery wall must be excised en bloc.8 9 If this is to be done safely the cerebral circulation must be maintained with a shunt and the excised vessel replaced with a reversed autogenous graft of saphenous vein. It is the impossibility of prediction before the operation that such a major procedure will be required that must restrict performance of the operation to vascular surgeons. The patient should be made fully aware of the risks before surgery.
Apart from the risk of stroke, which should be minimal (less than 1%), the only other risk is damage to the hypoglossal or vagus nerves resulting in an awkward tongue or a husky voice. There are no clinically apparent problems from the removal of both carotid bodies in bilateral cases, but a bilateral subintimal dissection around the carotid sinuses may leave the patient with an unstable blood pressure. Vancomycin is recommended for patients who are allergic to penicillin and need protection against Streptococcus viridans endocarditis associated with dental extraction. Many bacteriologists would consider erythromycin preferable, however, and it is certainly cheaper. If vancomycin is chosen a single dose of 1 g should be injected intravenously shortly before extraction.4 Hook and Johnson5 reviewed 15 patients treated for bacterial endocarditis with vancomycin. This drug was chosen because of allergy to penicillins and cephalosporin in six patients, bacteria resistant to other antibiotics in another six patients, culture-negative endocarditis in two patients, and one patient was given vancomycin as initial treatment. Thirteen patients were cured with no serious drug toxicity. These authors recommended vancomycin as the reserve drug for Strfaecalis and Str viridans endocarditis.
Vancomycin has also been used for staphylococcal infections at the site of the shunt in patients being treated with regular haemodialysis.6 Six anuric patients were treated with a 1 g dose of vancomycin every seven days and a satisfactory response was obtained in five. As it is bactericidal, normally almost entirely excreted by the kidney, and is not removed by dialysis, vancomycin is particularly suitable for such difficult infections.
It is, however, in the management of pseudomembranous colitis that vancomycin has found an undisputed role as firstline treatment. A regimen of 500 mg vancomycin daily by mouth will result in the disappearance of Clostridium difficile and its toxin which are responsible for the colitis. Keighley et al7 gave vancomycin for the treatment of pseudomembranous colitis in a randomised controlled trial. Of 16 patients with high titres of the neutralised Cl difficile toxin, nine received 125 mg vancomycin four times a day and seven placebo. At the end of five days' treatment faecal toxins were present in one patient given vancomycin and in five controls. Vancomycin caused disappearance of Cl difficile from the stools in all except one patient, whereas toxicogenic strains persisted in all but one of the controls. Possibly a lower dose may be just as efficacious, and this is under investigation.
The most serious toxic effects attributed to vancomycin are tinnitus, decreased auditory acuity, and deafness, all of which have been reported when serum concentrations exceed 90-100 mg '1. Ideally peak concentrations should be kept in the region of 10-20 mg/18-which should be both therapeutic and safe for normal patients and also for those with diminished renal function. Vancomycin may cause thrombophlebitis, so that veins should be used in rotation and the antibiotic should be diluted in 250 ml physiological saline or 5% glucose and given over 30 minutes.
Vancomycin is expensive and it should be reserved for these specific indications. Intravenous treatment costs about £40 a day and oral treatment some £8 a day. Probably the high cost and potential toxicity will help to preserve this very useful agent from abuse, which experience shows usually leads to resistance emerging-a rare problem as yet with vancomycin. 
